Foresti V, Parisio E, Ricci G
U.S.S.L. n. 75/1, Milano.
Minerva Med. 1987 Sep 15;78(17):1305-11.
Two patients with signs of hypermineralcorticism and suppressed plasma aldosterone levels are reported. For both patients the use of a nasal spray containing 9 alpha-fluoroprednisolone had been ascertained, the withdrawal of which was followed by the normalization of the clinical picture as well as by the normal reactivity of the renin-aldosterone system. The endocrine studies excluded the presence of enzymatic defects or the hypersecretion of minor mineralocorticoids. The tests with angiotensin II and ACTH did not result in an increase in aldosterone, which instead increased in a significant way after metoclopramide, even with still suppressed basal values. Since the PRA was normal at the time of the metoclopramide test, a persisting inhibition of the factors directly controlling aldosterone secretion by 9 alpha-fluoroprednisolone could be possibly envisaged. An interesting findings was the onset of severe hypokalemia, conditioning rhabdomyolysis with myoglobinuria in patient 1, after a treatment of few weeks only. Since the factitious use of mineral corticoids is not taken into account, the need of an accurate collection of case history in the differential diagnosis of hyporeninemic hypoaldosteronism with hypokalemia is stressed.
报告了两名患有高盐皮质激素血症体征且血浆醛固酮水平受抑制的患者。已确定两名患者均使用了含有9α-氟泼尼龙的鼻喷雾剂,停用该喷雾剂后,临床症状恢复正常,肾素-醛固酮系统的反应性也恢复正常。内分泌研究排除了酶缺陷或微量盐皮质激素分泌过多的情况。血管紧张素II和促肾上腺皮质激素试验未导致醛固酮增加,而甲氧氯普胺治疗后醛固酮反而显著增加,即使基础值仍受抑制。由于甲氧氯普胺试验时血浆肾素活性正常,因此可以设想9α-氟泼尼龙对直接控制醛固酮分泌的因子仍有持续抑制作用。一个有趣的发现是,仅在几周治疗后,患者1就出现了严重低钾血症,继而引发横纹肌溶解伴肌红蛋白尿。由于未考虑到人为使用盐皮质激素的情况,强调了在鉴别诊断低肾素性低醛固酮血症伴低钾血症时准确采集病史的必要性。